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some with round normal morphology, some with sickling showing
elongation and bending (7).1. Introduction
Sickle cell disease (SCD) is an inherited disorder, characterized
by defective hemoglobin (Hb) synthesis with production of an
abnormal form, known as sickle hemoglobin (Hb S). Under
low oxygen concentrations, red blood cells (RBCs) that con-
tain (Hb S) become irreversibly deformed (sickle shaped) and
rigid. This, in turn, impedes their ability to pass through nar-
row capillaries, with frequent clotting and thrombosis. Eventu-
ally, this leads to multiple repetitive vascular occlusion with
frequent attacks of intractable painful episodes and progres-
sive organ damage (1,2).
1.1. Incidence
Sickle cell anemia (SCA) affects millions throughout the
world. It is particularly common among people whose ances-
tors come from sub-Saharan Africa; Spanish-speaking regions
(South America, Cuba, and Central America); Saudi Arabia;
India; and Mediterranean countries such as Turkey, Greece,
and Italy. In the Unites States, it affects around 72,000 people,
most of whose ancestors come from Africa. The disease occurs
in about 1 in every 500 African-American births and 1 in every
1000–1400 Hispanic-American births. About 2 million Ameri-
cans, or 1 in 12 African Americans, carry the sickle cell trait
(3). SCD in Saudi Arabia is considered one of the major public
health problems in the Eastern province (4,5).
1.2. Pathophysiology
SCD is caused by mutation in the b-globin chain, whose gene
is located on chromosome number 11, causing the hydrophilic
glutamic acid to be replaced with the hydrophobic amino acid
Valine at position 6 of the beta chain. The association of two
a-globin subunits with two mutant b-globin subunits forms
hemoglobin S (Hb S). Under environmental low oxygen
concentrations or increased body oxygen demands (e.g. highaltitude or exercise stress), this mutant hemoglobin will cause
aggregation of hemoglobin molecules. These aggregates per-
manently distort RBCs into a sickle shaped ones with lost elas-
ticity i.e. RBCs fail to return to normal shape when normal
oxygen tension is restored. Consequently, these rigid deformed
RBCs fail to pass smoothly through the narrow capillaries,
leading to vessel occlusion and ischemia (6) Fig. 1 (7).
There are different forms of the disease determined by the
inherited genotype. If it is of homozygous pattern i.e. (Hb
SS), the blood will have no normal hemoglobin particles and
phenotypically termed sickle cell anemia (SCA). Heterozygous
genotype, in which the patient inherits a sickle cell gene from
one parent and a normal gene from the other parent forming
Hb SA, is phenotypically expressed as sickle cell trait. Also,
other heterozygous types of Hb S may form due to
Fig. 2 Lateral X ray of dorsal spine showing central vertebral
body depression of multiple dorsal vertebrae with typical H-
shaped vertebrae.
Sickle cell anemia: Imaging from head to toe 549combination with another different abnormal gene, such as
sickle-hemoglobin C disease (Hb SC) or Hb S-beta thalassemia
(Hb S-tha) (8).
Normally, the adult blood is formed mainly of hemoglobin
A (96–97%), which consists of two alpha and two beta chains.
The remaining small percentage is formed of hemoglobin A2
(two alpha and two delta chains) and hemoglobin F (two alpha
and two gamma chains). In Hb SS patients, severe anemia is
caused by excessive frequent destruction of the short lived
red cells, because of their abnormal shape and elasticity. The
bone marrow rate of hematopoiesis is signiﬁcantly increased,
but does not match the rate of destruction. Sickle cells survive
only 10–20 days, in comparison with normal RBCs that live
90–120 days. In sickle trait patients with Hb SA, considering
that their normal chromosomal allele is able to produce over
50% of the hemoglobin, there is no severe hemolytic crisis as
SCA patients. They may have symptoms only if they are se-
verely deprived of oxygen (9).Fig. 3 Triphasic contrast enhanced CT scan (A) Axial nephrographic
bilateral hypoattenuated expanding non enhancing soft tissue mass le1.3. Clinical presentation of SCA
Acute painful vaso-occlusive crises are the most common clin-
ical presentations of SCA. Around 50% of patients with SCA
experience a painful crisis before the age of ﬁve. The skeletal
system is the most frequently affected system with repeated
complaints of acute severe pain which may involve different
parts. Also, these vaso-occlusive crises may involve any organ
with different manifestations according to the affected site
(10).
2. Imaging of SCA
This article tries to cover most of the radiological manifesta-
tions, with different imaging modalities, in different systems af-
fected by the disease, as organ-based approach. Systems are
arranged in a descending order according to frequency, as we
encountered in practice. Generally, it is agreed that the most
commonly affected system is the musculoskeletal system (9).
2.1. Musculoskeletal complications
The skeletal involvement in SCD is mediated through different
pathophysiological mechanisms. These are excessive intramed-
ullary and extramedullary hematopoiesis, ischemic osteonecro-
sis and increased susceptibility of osteomyelitis. Excessive
intramedullary hematopoiesis is stimulated by severe anemia
caused by frequent hemolysis, which causes expansion of the
intramedullary hematopoietic space (red marrow). These high
demands of hematopoiesis stop conversion of red marrow into
fatty marrow and re-convert the already formed fatty marrow
into red marrow. Widening of osseous medullary spaces leads
to osteopenia and thinning of cortical bone, making the bone
vulnerable to pathologic fractures. Widening of the skull di-
ploic space, together with some trabecular destruction and
thickening of other trabeculae produce the X ray picture of
hair-on-end skull, which is pathognomonic for hemolytic ane-
mia. The vertebral osteopenic texture can result in central ver-
tebral body compression giving a typical picture of multiple H-
shaped vertebrae that are commonly seen in dorsal spine
(11,12) Fig. 2.
Regardless, extramedullary hematopoiesis is not a constant
feature of SCA; as it is more commonly seen in thalassemia orphase. (B) Coronal reformats in delayed excretory phase showing
sions in the area of the renal pelvises.
Fig. 4 Plain X ray of right (A) and left (B) hands of an infant
showing typical ﬁndings of bilateral sickle cell dactylitis, seen as
soft tissue swellings, metatarsal and phalangeal expansion and
multiple osteopenic patches.
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of SCA patients (13). It may involve liver, spleen or paraverte-
bral spaces, less likely kidneys, adrenal glands, and skin. Sec-
tional imaging by computed tomography scan (CT) or
magnetic resonance (MRI) can perfectly diagnose these
masses. They usually show CT isodensity and intermediate sig-
nal intensity on both T1-weighted and T2-weighted MR
images, with no or minimal post contrast enhancement. Some-
times, biopsy is mandatory to conﬁrm the imaging diagnosis
(13–17) Fig. 3.
Osteonecrosis (avascular necrosis or aseptic necrosis) due to
ischemic bone insults is one of the most frequently encountered
complications of SCA. Ischemia and consequent infarcts
mainly involve the medullary cavities of the shafts and epiph-Fig. 5 (A) X ray AP of knee joint showing distal femoral and proxim
of right shoulder showing extensive humeral head, metaphysis and uppyses of long bones, body of spinal vertebrae and pelvic bones.
Also, it may involve small tubular bones of hands or feet,
which is known as sickle cell dactylitis or hand-foot syndrome.
This syndrome usually presents before peripheral skeleton
fatty marrow transformation i.e. before the age of six. X ray
of affected hands or feet can show soft tissue swelling with
periosteal reaction 7–10 days after the onset of severe pain. La-
ter on, it shows medullary expansion, cortical thinning and
osseous lucent patches. It mainly involves the metacarpal/
metatarsal bones and proximal phalanges. Usually, it is self-
limited with spontaneous resolution in few weeks; however
bone destruction and resultant deformity may be seen (9,18)
Fig. 4.
X rays of AVN in long bone shafts show relative delayed
ﬁndings of mixed lucent and sclerotic patches, sometimes asso-
ciated with periostitis and periosteal reaction if the cortex is in-
volved. MRI, which is the most sensitive tool, shows early
positive ﬁndings that are usually simultaneous with the pa-
tient’s complaint. First, it shows bone marrow edema as med-
ullary T2w hyperintense and T1w hypointense signal. Shortly
afterward, it will show serpentine geographic medullary patch
of different sizes according to severity of insult, with T1 low
signal and T2w hyperintense signal of granulation tissue sur-
rounded by outer hypointense ring. This can be explained by
the formation of central serpentine granulation tissue sur-
rounded by sclerotic ring. Also, this granulation tissue may
show enhancement in post contrast scans (9,12,19) Fig. 5.
AVN of long bones epiphysis is considered one of the com-
mon features of SCA. The femoral head is the most common
site, followed by the humeral head. It can occur in a single
or several bones at the same or different times. X ray is usually
normal in the early stage of the disease or may show regional
osteopenia. Afterward, it usually shows mixed lucent and scle-
rotic patches, crescent shaped subchondral lucency, collapse,
fragmentation and eventually, secondary osteoarthritis
(9,12,19). MRI is the most sensitive means of diagnosingal tibial metadiaphyseal sclerotic patches. (B) Coronal STIR MRI
er shaft heterogeneous signal intensity, both due to osteonecrosis.
Fig. 6 Bilateral femoral head AVN. (A) Plain X ray AP pelvis showing bilateral femoral head collapse and sclerosis. (B) Coronal MRI
STIR showing femoral head double line sign, collapse and secondary osteoarthritis of hip joints.
Fig. 7 MRI of young female patient with septic elbow arthritis: Sagittal T2w (A) Sagittal STIR (B), Axial T1w (C) and Axial T1w with
contrast, showing joint effusion, marginal cortical destruction (Arrow in A), and synovial thickening showing post contrast enhancement
(Notched arrows in C and D), extensive periarticular soft tissue edema (chevrons in B).
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552 M. Agha et al.epiphyseal AVN, because it is indispensable for early diagnosis
and accurate staging. MRI facilitates a better response to
treatment because it helps early correct therapeutic applica-
tion, avoiding complications of delayed diagnosis. MRI may
also help and guide interventional procedures such as core
decompression as well as judge and check therapeutic response
(9,12,19) Fig. 6.
Osteomyilitis and septic arthritis are also common compli-
cations in patients with SCA. This may be due to immune
compromised status of these patients and the presence of oste-
onecrotic lesions. Osteomyelitis and septic arthritis were re-
ported in some researches to be 18% and 7% of SCA
patients, respectively (9,20,21). Sometimes, differentiating
acute osteomyelitis from osteonecrosis in SCA patients is difﬁ-
cult. Plain X ray and CT scan have a limited role in such dif-
ferentiation, as the major positive signs could be shared by the
two pathologies, like periosteal reaction and bone destruction.
Also, paraosseous soft tissue and subperiosteal collection,
which could be seen by Ultrasound (US) is not clear differen-
tiating point. Even US guided aspiration and culturing the
drained collection are not completely reliable, as blood culture
was reported to be positive only in 50% of patients. According
to variability of tracer uptake in different phases of AVN, also
scintigraphy has limited speciﬁcity (9,21).A
C
Fig. 8 MRI of bilateral femoral multifocal osteomyelitis. (A) Axial
contrast axial T1w. Fat sat sequences, showing patchy enhancing me
(notched arrows) and ring enhancing collections (chevron).MRI is the most sensitive, speciﬁc and promising imaging
tool of choice for such differentiation and early diagnosis.
Regardless, there are some common shared signs like bone
marrow and soft tissue edema, the pattern of enhancement
in post contrast images is one of the major differentiating
points. Those with osteomyelitis showed a thick, irregular ring
enhancement around a non-enhancing center, while medullary
infarction showed a long segmental serpiginous medullary
enhancement. Also, the presence of sequestra, involucra and
paraosseous abscess highly supports the diagnosis of osteomy-
elitis. So, it is now widely accepted, that MR imaging is the
most sensitive and speciﬁc imaging tool for early diagnosis
of AVN and osteomyelitis, more sensitive and speciﬁc than
other tools, even scintigraphy. Osteomyelitis may develop on
the top of predisposing infarct which makes it quite difﬁcult
to detect through imaging (9,21,22) Figs. 7 and 8.
2.2. Neurological complications
Cerebrovascular accidents (CVA) are the most common cere-
bral insults reported in SCA patients, accounting for about
12% of deaths in these patients. Vasculopathy of the major
cerebral vessels is the main responsible pathology. CT angiog-
raphy (CTA) or magnetic resonant angiography (MRA) orB
D
T1w. (B) Post-contrast axial T1w. (C) Coronal STIR. (D) Post-
dullary foci (arrows) and paraosseous extensive soft tissue edema
Fig. 9 MRI T1w axial (A) and Sagittal (B) show right high parietal hemorrhagic infarction. MRV coronal (C) and Sagittal (D) reformat
clearly show right transverse sinus thrombosis, supporting diagnosis of hemorrhagic venous infarct.
Fig. 10 MRI axial T1w sequence with (A) and without (B) contrast showing extensive left parietal intraaxial vascular collaterals
secondary to left internal carotid ischemia (moyamoya).
Sickle cell anemia: Imaging from head to toe 553conventional digital subtraction angiography (DSA) can show
this cerebral vasculopathy as arterial tortuosity, stenosis orocclusion Fig. 9. Also, arterial intimal damage may be precip-
itated by a high velocity blood ﬂow and the sickle RBC
Fig. 11 (A and B) Axial IV contrast CT scan chest showing enlarged main pulmonary trunk and the major right and left divisions,
consistent with pulmonary hypertension.
Fig. 12 (A) PA and (B) left lateral chest X ray showing segmental dilatation of the left ventricle due to post MI aneurysm (echo proven).
554 M. Agha et al.aggregates that permit the adherence of RBCs to the vascular
endothelium leading to intimal hyperplasia, thrombosis or
aneurysmal formation. Severe forms of intracranial arterial
stenosis may cause chronic ischemia, which promotes develop-
ment of many types of collateral, termed moyamoya which is a
Japanese word meaning puff of smoke. It is a non-speciﬁc sign
that could be seen in other types of chronic ischemia (23,24)
Fig. 10.
2.3. Cardiovascular complications
Previously, owing to a short life span of SCA patients, there
were no considerable recognized cardiovascular complications.
However nowadays because of the relatively increased longev-
ity of those patients, cardiovascular complications are more
pronounced. The most frequent cardiovascular complications
are pulmonary hypertension (PHT), myocardial infarct and
heart failure (25).
Precapillary type of PHT, which may develop in older SCA
patients, may be explained by the vasoconstrictive effect of the
high-viscosity sickled RBCs in the pulmonary arterial circula-
tion. Also, surgical splenectomy or functional asplenia, pul-
monary thromboembolism, interstitial lung ﬁbrosis, other
vasoactive mediators such as placental growth factor andendothelin (ET)-1 may contribute to the development of
PHT. Best diagnostic clue is dilatation of the central pulmon-
ary arteries with rapid tapering and right ventricular hypertro-
phy, which is easily seen in plain chest X-ray. Also, it can be
clearly identiﬁed in CT or CTA scans, in which accurate mea-
sures of the diameter of the main pulmonary artery can be
done (Normally = 28.6 mm). It is measured at the site of the
arterial bifurcation, perpendicular to long axis. Normally,
the normal main pulmonary artery is smaller in diameter than
the adjacent ascending aorta. MRI is less sensitive and techni-
cally difﬁcult in these patients, because they are commonly
dyspneic with difﬁcult breath hold (25) Fig. 11.
Also, chronic anemia in SCA patients causes cardiac cham-
ber dilation and a compensatory increase in left ventricular
mass, which can be accurately estimated by Echocardiography.
This is often accompanied by left ventricular diastolic dysfunc-
tion. Direct myocardial damage can occur in SCA patients
without predisposing coronary artery diseases. This may be ex-
plained by the fact that disproportion between myocardial
oxygen supply and demand results in myocardial ischemia
and infarction. So, young SCA patients or even children may
have ECG ischemic changes with reported cases of myocardial
infarcts in children, with possible chronic complications e.g.
ventricular aneurysms. This may be one of the possible
Fig. 13 HRCT scan (A and B) showing bilateral multiple inﬁltrates of ACS as well as bilateral pleural effusion.
Fig. 14 (A and B) HRCT scan showing right upper lobar anterior segment cystic bronchiectatic changes.
Fig. 15 Nephrographic phase contrast enhanced CT scan shows
right renal wedge shaped cortical infarct (arrow).
Sickle cell anemia: Imaging from head to toe 555etiologies of sudden death, which is an increasingly recognized
problem among SCA patients, thus cardiac investigations are
mandatory to recognize and treat high-risk patients (26,27)
Fig. 12.
Multidetector CT scan (MDCT) and newly introduced fast
MRI sequences had conﬁdently replaced the previous widely
used isotope scanning, in the diagnosis of MI. MDCT can pro-
vide additional helpful information about cardiac cavities’
dimensions and wall thickness, as well as MI complications
e.g. aneurysms or intracardiac thrombi. Also, MRI can show
acute MI and accurately delineate the size of the infarct seg-
ment within 30 min of its outset. Infarct is seen as hyperintense
myocardial edema on black-blood T2-weighted images (e.g.
Half-Fourier, single-shot fast spin echo with double inversion
recovery). MI diagnosis by MRI can be made well before clas-
sic troponin positive test. Flow up MRI studies can show the
previously mentioned complications as well as a permanent
myocardial scar, which is inevitable sequel of infarct, as an
enhancing patch in delayed post contrast images (28,29).
2.4. Pulmonary complications
Acute chest syndrome (ACS) is one of the most common
causes of hospitalization and even death of SCA patients.
ACS is deﬁned as a new pulmonary inﬁltrate on chest radio-graph, associated with fever, cough, wheezes, dyspnea and
tachypnea. There is no clear single pathogenesis of this syn-
drome; however multiple different factors (separate or com-
bined) may be incriminated e.g. pulmonary fat embolism,
hypoxemia and atelectasis due to shallow breath secondary
to painful rib infarction, as well as pulmonary vascular
obstruction. X ray shows single or multiple areas of pulmon-
ary inﬁltrate mainly involving the middle and lower lobe air-
space (30) Fig. 13.
Fig. 16 Post contrast CT scan Axial (A and B) and coronal reformat (C and D) showing right renal upper polar carbuncle (Arrow) with
massive perinephric collection (chevron).
556 M. Agha et al.Pleural effusion may be seen, however it does not help
much to differentiate infectious from non-infectious causes
of ACS. Non-infectious inﬁltrates will clear more rapidly than
infectious ones, so, follow up chest X rays are recommended to
monitor the resolution of the disease. Sputum and blood cul-
tures should be done in non-resolved types to identify respon-
sible bacterial agents, if present. Also, ﬁberoptic bronchoscopy
and broncho-alveolar lavage (BAL) can provide much help in
the diagnosis of fatty embolism (30,31).
Patients with SCA may develop obstructive or restrictive
lung diseases, when there is a progressive decline in the pul-
monary functions after a preceding history of several attacks
of acute chest syndrome. This may be explained by established
ﬁbrotic lung changes from repeated episodes of pulmonary
infective and vaso-occlusive events. High resolution CT scan
(HRCT) shows these interstitial changes, that are of reticular
or reticulonodular pattern and may be associated with traction
bronchiectasis (32) Fig. 14.2.5. Renal complications
Sickle cell nephropathy is another debilitating complication of
SCA, which develops as a result of sickling of RBCs in renal
circulation. This leads to ischemia causing cortical infarctions
and papillary necrosis, as well as renal tubular injury Fig. 15. It
may be associated with proteinuria, nephrotic syndrome, azo-
temia, hyperuricemia, uremia and ﬁnally renal failure. US is a
good diagnostic imaging modality for nephropathic changes,
as it shows cortical echogenicity accentuation, loss of cortico-
medullary differentiation, increased resistive index (RI) on
Doppler examination and shrunken size. The deterioration in
renal function tests with decreased creatinine clearance are
the most important landmarks and may precede or be dispro-
portionate to imaging ﬁndings. Also, there is a possible super-
added bacterial infection of the scarred renal tissues and
functional tubule abnormalities in conjunction with the
Fig. 17 Non contrast CT scan in two different SCA patients showing splenic infarct (A), seen as capsular based irregular triangular
shaped hypodense patch (Arrow) and splenic abscess (B), seen as splenic cystic swelling showing air ﬂuid levels (arrow).
Fig. 18 (A and B) Axial fat-saturated fast spin-echo (SE) T2-weighted MR image shows the signiﬁcant hypointense signal of the liver
and spleen, sparing the kidneys and pancreas, supporting diagnosis of secondary hemochromatosis.
Sickle cell anemia: Imaging from head to toe 557compromised immunity, leading to suppuration and some-
times abscess formation (33,34) Fig. 16.
2.6. Abdominal complications
2.6.1. Spleen
Sickle cell clots cause ischemic vascular occlusion, which fre-
quently affects different parts of the abdominal structures.
The most commonly involved organ is the spleen, which is af-
fected in almost all patients with SCA. Repeated splenic infarc-
tions that start within the ﬁrst 18–36 months of life, in
association with the dates of disappearance of protective Hb
F, result in hyposplenism or even asplenism. Splenic atrophy
is a major etiology of compromised immune status of these pa-
tients and increased susceptibility to infections (35,36)
Fig. 17A.
Splenic infarction usually presents with left upper quadrant
pain and sometimes nausea, vomiting, friction rub over the
splenic area, and leukocytosis. Imaging appearance of splenic
infarction depends on the timing of imaging and the size of
the infarct. In well-established cases both ultrasound and CT
are almost equally sensitive, however in early acute stage, con-
trast enhanced CT scan is the most sensitive tool of imaging.The typical infarct is seen as a hypodense non- or poorly
enhancing wedge, with apex pointing toward the hilum. Later
on, these infarcts may resolve completely or leave a permanent
scar seen as contracted segment, or liquefy with possible ab-
scess formation. Also, multiple small infarcts or global infarct
of the whole spleen are reported in the imaging ﬁndings (37–
39) Fig. 17B.
2.6.2. Liver
Liver infarction in SCD was reported in 34% of autopsies.
Regardless the dual hepatic blood supply, the sickle blood high
viscosity predisposes to infarction. Acute sickle hepatic crisis
affects about 10% of patients admitted for painful crisis. It
usually simulates acute cholecystitis with right upper quadrant
pain, fever and leucocytosis, however unlike cholecystitis; the
liver is enlarged and tender. Intrahepatic cholestasis is rare;
however it is considered severe and may be a fatal form of he-
patic crisis due to acute massive hyperbilirubinemia. MDCT is
the most sensitive imaging tool for the diagnosis of these in-
sults (40,41).
Mainly, chronic liver disease in SCA is due to the develop-
ment of secondary hemochromatosis or hepatitis, which may
lead to end stage hepatic cirrhosis, even among young patients.
A B
Fig. 19 Arterial phase contrast enhanced CT scan abdomen shows: (A) Normal ﬁlling of the celiac artery (arrow) and (B) lack of ﬁlling
of the thrombosed superior mesenteric artery (notched arrow). Right renal cortical infarct is seen as well (curved arrow in A).
Fig. 20 MRCP showing multiple small gall stones (arrows) and
CBD stone (notched arrow) with minimal CBD dilatation.
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scores among SCA patients. Hepatic hemochromatosis is due
to hepatic iron overload secondary to excessive accumulation
of transfused iron leading to increased total body content of
iron to 50–60 gm. (normally, less than 6 gm.) This is explained
by increased gastrointestinal absorption as a result of intensive
erythropoiesis, and continuous hemolysis. Non contrast CT
scan shows homogeneously increased liver density (75–
135 HU (normal 45–65 HU)). MR ﬁndings are generalized de-
crease of signal intensity of the liver and spleen in T1w and
T2w images. Involvement of the spleen differentiates this type
of secondary hemochromatosis from primary type, in which
the spleen is spared (42) Fig. 18.
2.6.3. Mesenteric vaso-occlusive crisis
Though it is not so common, mesenteric arterial or venous
thrombosis could be a life-threatening complication of SCA.
After, the advent of MDCT scan, CTA is now considered
the diagnostic tool of choice for this insult with high sensitivity
scores. This is because; MDCT allows rapid volumetric data
acquisition allowing perfect spatial resolution of large ana-
tomic volume. From these data, retrospective post-processing
is done with application of one or more reformat software
e.g. Multiplanar reformat (MPR), maximum intensityprojection (MIP), curved multiplanar reformatted images
(CMPR) and 3D volume rendering (VR) visualization. These
applications signiﬁcantly increase the sensitivity of the images
to approximate or even it may overcome the results of invasive
conventional angiography, which was previously considered
the ideal tool of investigation. CTA was reported in some stud-
ies to have a speciﬁcity of 94% with a sensitivity of 96% in the
diagnosis of such mesenteric vaso-occlusive insults (43,44)
Fig. 19.
2.6.4. Gall bladder
A high incidence of gall bladder multiple pigmented gall stones
is clearly demonstrated among SCA patients due to high bili-
rubin levels. Ultrasound is sufﬁcient for the diagnosis of these
stones, except if complicated by biliary tree or CBD obstruc-
tion, then MRCP is recommended for the diagnosis (45)
Fig. 20.
2.6.5. Sequestration syndrome
It is rapid pooling of the blood within solid organs, commonly
the spleen, less commonly the liver, causing acute organomeg-
aly. If this sequestration happens, it deﬁnitely occurs before the
development of hyposplenism. This pooling, in turn, results in
intravascular volume depletion and depreciation of hematocrit
values (a drop of >2 g/dL is considered signiﬁcant). If severe,
children may present with a rapidly enlarging spleen, abdomi-
nal fullness, pallor, tachycardia, and tachypnea. Fulminant
cardiovascular crisis is the expected fate of suddenly resolved
sequestration, due to rapid rise in Hb with resultant hypervo-
lemia, heart failure, and intracerebral hemorrhage. Therefore,
the diagnosis of sequestration syndrome must be considered in
a child with any of the above symptoms or signs, especially the
unexplained acute splenic enlargement. Lifesaving treatment
consists of blood transfusion, or the infrequently applied sple-
nectomy (46).
2.6.6. Less common complications
Acute pancreatitis may develop with or without clear predis-
posing factors e.g. gall stones. If there is no clear predisposing
factor, it may be a result of microvascular occlusion and ische-
mic injury. Non-doubtfully, CECT scan is the most reliable
imaging tool of acute pancreatitis with accurate determination
of the degree of severity, according to the widely used
Balthazar grading system. This imaging grading score guides
Fig. 21 (A and B) CT scan with IV contrast shows severe diffuse pancreatic swelling with heterogeneous patchy enhancement and
multiple non enhancing necrotic foci (arrows).
Fig. 22 (A) Frontal abdominal radiograph showing nodular haustral thickening, (B) Barium enema showing serrated appearance of
transverse colon and (C) CT scan showing the classic accordion sign of pseudomembranous colitis (52).
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interventional, according to the degree of severity and compli-
cations that may rapidly develop e.g. abscess, splenic or mesen-
teric vein thrombosis. Also, CT scan can detect possible
chronic complications on delayed examinations, like chronic
pancreatitis or pseudocysts (47) Fig. 21.
Peptic ulcer is infrequently encountered in patients with
SCA, however it is characteristically not associated with high
acid outputs. This may suggest chronic mucosal ischemic insult
as possible etiology, so it is resistant to medical treatment (48).
Reports of uncommon colonic abnormalities include acute
necrotizing colitis in adults, pseudomembranous colitis
(PMC) in a child, ischemic colitis, and life threatening toxic
megacolon. Pathogenesis of these inﬂammatory complications
seems also to be due to intestinal ischemic microvascular
occlusion (49). Barium enema is contraindicated for imaging
of these intestinal lesions, if associated with acute abdomen
due to a high risk of perforation. CECT with oral water solu-
ble contrast is the imaging tool of choice, and may show a long
segmental intestinal wall thickening which is irregular and
shaggy, compared to symmetrical homogeneous pattern in
Crohn’s disease. Also, it may show the famous accordion sign
which represents trapped contrast between thickened edema-
tous colonic haustral folds (50) Fig. 22 (51).
3. Treatment of SCA
So far, SCA has no deﬁnite curative therapy, however the dif-
ferent therapeutic tools are applied in an attempt to relieve
symptoms and treat complications. Blood and marrow stem
cell transplants still have lower successful indices, with re-
ported many complications and high rejection scores of non-
matching donor’s stem cells. However this stem cell transplant
is still the only promising curative therapy for those children
suffering from SCA. Regardless, it is still not a recommended
therapeutic option for adults; researches are going-on for cov-
ering older age groups (51).
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